Apr 28, 2017

Super-sized drug price hikes are gone. The profits aren't.

Go deeper

A venture capitalist wants to mimic blockbuster drugs at a lower price

A venture capitalist is launching a company today to create new drugs that mimic the effects of blockbuster drugs, and then sell them to insurers and hospital systems at a lower price, STAT reports.

Between the lines: The key question is whether insurers and hospitals will buy these new drugs over their competitors.

Go deeperArrowJan 13, 2020

Health care profits dip, but stocks soar

Data: FactSet; Chart: Axios Visuals

Health care industry earnings fell 18% in the third quarter of this year, compared with the same period in 2018, due in part to the costs associated with opioids litigation, according to the Axios tracker of almost 170 health care companies.

Yes, but: The industry still churned out a 6.1% profit margin, and health care stocks are at the highest they've been all year because Wall Street foresees a very profitable election year.

Go deeperArrowDec 17, 2019

The medications that are thrown away

Data: Centers for Medicare & Medicaid Services; Table: Axios Visuals

Last year, Medicare paid for $725 million worth of expensive medications administered in outpatient clinics — things like chemotherapy drugs — that ended up being discarded, according to new data released by the federal government.

Why it matters: Although that amount is just 2% of what Medicare paid for those types of infusion drugs, that's still a "very astonishing amount of waste," said Rena Conti, a health economist at Boston University who has studied the issue.

Go deeperArrowJan 6, 2020